{
  "headers": [
    "INVESTOR NARRATIVE",
    "col_2",
    "col_3",
    "col_4",
    "col_5"
  ],
  "rows": [
    {
      "INVESTOR NARRATIVE": "THE PITCH (Why This Is Investable)",
      "col_2": null,
      "col_3": null,
      "col_4": null,
      "col_5": null
    },
    {
      "INVESTOR NARRATIVE": "1. Category is proven: LMNT did $66M in 2024 with powder electrolytes. Premium hydration is real.",
      "col_2": null,
      "col_3": null,
      "col_4": null,
      "col_5": null
    },
    {
      "INVESTOR NARRATIVE": "2. Marine plasma is validated: Seaonic exists, has customers, charges $69/box. Market is there.",
      "col_2": null,
      "col_3": null,
      "col_4": null,
      "col_5": null
    },
    {
      "INVESTOR NARRATIVE": "3. Gap in market: Seaonic is the only marine plasma DTC brand at scale. No credible #2.",
      "col_2": null,
      "col_3": null,
      "col_4": null,
      "col_5": null
    },
    {
      "INVESTOR NARRATIVE": "4. Arbitrage opportunity: Same positioning, 10-15% lower price, proven direct response playbook.",
      "col_2": null,
      "col_3": null,
      "col_4": null,
      "col_5": null
    },
    {
      "INVESTOR NARRATIVE": "5. De-risked execution: Ads validated before we take your capital. You're funding scale, not experiments.",
      "col_2": null,
      "col_3": null,
      "col_4": null,
      "col_5": null
    },
    {
      "INVESTOR NARRATIVE": "6. Clear exit path: TSG Consumer, L Catterton actively acquiring wellness/supplement brands at 4-6x EBITDA.",
      "col_2": null,
      "col_3": null,
      "col_4": null,
      "col_5": null
    },
    {
      "INVESTOR NARRATIVE": "7. Small check, big upside: $30-50K gets you into a business targeting $5M revenue, $1.5M EBITDA, $6-9M exit.",
      "col_2": null,
      "col_3": null,
      "col_4": null,
      "col_5": null
    },
    {
      "INVESTOR NARRATIVE": "DEAL TERMS",
      "col_2": null,
      "col_3": null,
      "col_4": null,
      "col_5": null
    },
    {
      "INVESTOR NARRATIVE": "Instrument",
      "col_2": "SAFE (post-money cap)",
      "col_3": null,
      "col_4": null,
      "col_5": null
    },
    {
      "INVESTOR NARRATIVE": "Raise Amount",
      "col_2": "$30-50K",
      "col_3": null,
      "col_4": null,
      "col_5": null
    },
    {
      "INVESTOR NARRATIVE": "Valuation Cap",
      "col_2": "$250-500K (depends on validation metrics at raise)",
      "col_3": null,
      "col_4": null,
      "col_5": null
    },
    {
      "INVESTOR NARRATIVE": "Investor Equity",
      "col_2": "~10-20%",
      "col_3": null,
      "col_4": null,
      "col_5": null
    },
    {
      "INVESTOR NARRATIVE": "Use of Funds",
      "col_2": "Inventory (33%), Ad scaling (30%), Working capital (37%)",
      "col_3": null,
      "col_4": null,
      "col_5": null
    },
    {
      "INVESTOR NARRATIVE": "Timeline to Revenue",
      "col_2": "2-3 weeks from funding",
      "col_3": null,
      "col_4": null,
      "col_5": null
    },
    {
      "INVESTOR NARRATIVE": "Timeline to Profitability",
      "col_2": "8-12 weeks",
      "col_3": null,
      "col_4": null,
      "col_5": null
    },
    {
      "INVESTOR NARRATIVE": "EXIT SCENARIOS",
      "col_2": null,
      "col_3": null,
      "col_4": null,
      "col_5": null
    },
    {
      "INVESTOR NARRATIVE": "Scenario",
      "col_2": "Trigger",
      "col_3": "Valuation",
      "col_4": "Likelihood",
      "col_5": null
    },
    {
      "INVESTOR NARRATIVE": "PE Acquisition (3-5 years)",
      "col_2": "$5M revenue, 30% EBITDA margin, 4-6x multiple",
      "col_3": "$6-9M valuation",
      "col_4": "PRIMARY PATH",
      "col_5": null
    },
    {
      "INVESTOR NARRATIVE": "Strategic Acquisition",
      "col_2": "Wellness conglomerate (Nestle Health, Unilever) buys category",
      "col_3": "$8-15M potential",
      "col_4": "OPPORTUNISTIC",
      "col_5": null
    },
    {
      "INVESTOR NARRATIVE": "Operator Buyout (18-24 months)",
      "col_2": "Operator buys out investors at 3-5x",
      "col_3": "$90-250K return on $50K",
      "col_4": "EARLY EXIT",
      "col_5": null
    },
    {
      "INVESTOR NARRATIVE": "Ongoing Distributions",
      "col_2": "Hold equity, receive profit distributions",
      "col_3": "20-40% annual yield",
      "col_4": "PASSIVE INCOME",
      "col_5": null
    }
  ],
  "row_count": 22,
  "sheet_name": "Investor Narrative",
  "sheet_index": 138
}